Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Journal of Pediatric Psychology|November 28, 2006
Reliability and validity of the Asthma Trigger Inventory applied to a pediatric populationBeatrice L Wood, Po Ann Cheah, JungHa Lim, et al.Journal of Clinical Immunology|December 10, 2009
Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiencyMelvin Berger, Paul J Pinciaro, Arthur Althaus, et al.Academic Medicine : Journal of the Association of American Medical Colleges|October 27, 2004
Developing resources to teach and assess the core competencies: a collaborative approachVirginia A Reed, G Christian Jernstedt, Mark Ballow, et al.The Laryngoscope|February 24, 2011
Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposisJoel M Bernstein, Cheryl Allen, Gary Rich, et al.Journal of Clinical Immunology|June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency DiseasesMark Ballow, Paul J Pinciaro, Timothy Craig, et al.Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2006
Association of depressive symptoms and disease activity in children with asthma: methodological and clinical implicationsJames Waxmonsky, Beatrice L Wood, Trudy Stern, et al.Pediatrics|October 3, 2003
Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)Elena E Perez, Aleksandra Bokszczanin, Donna McDonald-McGinn, et al.Journal of Pediatric Psychology|November 25, 2006
Family emotional climate, depression, emotional triggering of asthma, and disease severity in pediatric asthma: examination of pathways of effectBeatrice L Wood, JungHa Lim, Bruce D Miller, et al.Journal of Clinical Immunology|November 13, 2013
Psychrobacter immobilis septicemia in a boy with X-linked chronic granulomatous disease and fulminant hepatic failurePanida Sriaroon, Araceli Elizalde, Elena E Perez, et al.International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.Pageof 9